Ralph Bell Metson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 0 Emerson Pl, Ste 2d E00 2d, Boston, MA 02114 Phone: 617-227-4366 Fax: 617-726-2894 |
Dr. Derrick T. Lin, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 |
Dr. Ramon A. Franco, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 |
Tania Hassanzadeh, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 830 Harrison Avenue, Ste 1400, Boston, MA 02118 Phone: 617-638-8124 Fax: 617-414-4953 |
Dr. Mark S Volk, MD, DMD Otolaryngology Medicare: Medicare Enrolled Practice Location: 333 Longwood Ave, Floor 3, Boston, MA 02115 Phone: 617-355-4556 Fax: 617-730-0337 |
Dr. Anthony Charles Nichols, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 243 Charles St, Ent Education, Boston, MA 02114 Phone: 617-573-3654 |
Dr. Pavan S Mallur, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 110 Francis St, Suite 6e, Boston, MA 02215 Phone: 617-632-7509 |
Dr. Andrew Larson, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3654 |
Dr. Joseph B. Nadol Jr., M.D. Otolaryngology - Otology & Neurotology Medicare: Not Enrolled in Medicare Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3632 |
Marianella Paz-lansberg, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 400, Boston, MA 02118 Phone: 617-638-8124 Fax: 617-414-4953 |
Mark A Vecchiotti, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 1400, Boston, MA 02118 Phone: 617-638-8124 Fax: 617-414-4953 |
Jacqueline Wulu, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Boston, MA 02118 Phone: 617-638-7066 |
Ayaka Iwata, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3653 |
Victoria Weyu Huang, Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-632-9236 |
Jason Kass, MDPHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave, Ste 1400, Boston, MA 02118 Phone: 617-638-8124 Fax: 617-638-6424 |
David Hyun Jung, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Massachusetts Eye And Ear Infirmary Div Of Otology, Boston, MA 02114 Phone: 617-523-7900 |
Andrew Holcomb, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3654 |
Mark A Varvares, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 |
Dr. Rahmatullah Rahmati, MBBS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-6113 |
Emily Gall, Otolaryngology Medicare: Medicare Enrolled Practice Location: 860 Washington St Fl 1, Boston, MA 02111 Phone: 617-636-7878 |
News Archive
BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.
A transition is a physical move from one location to another with a stay of at least one night. For older adults, especially those with dementia, some transitions may be unavoidable and necessary. However, unnecessary transitions are linked to problems such as medication errors, hospital readmissions, and increased risk of death.
The U.S. Food and Drug Administration (FDA) says two more companies have recalled their products, because they may contain spinach linked to a food poisoning outbreak, which has caused serious illness and at least one death.
Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer-research that will likely improve the diagnosis and treatment of high-risk patients.
› Verified 4 days ago